The Dolphin CPAP includes both bubble CPAP therapy and pulse oximetry
monitoring, making it ideal for providing respiratory support to spontaneously
breathing neonates.
This user manual is intended for healthcare professionals.
should be read before use.
according to the
Reprocessing (CPAP)
section.
Bubble CPAP Therapy
The Dolphin CPAP provides precisely
FiO
2
and pressure settings. Flow rate and
FiO
2
are easily adjusted by pressing the
arrows on the CPAP display. Pressure is
set by moving the column to the desired
underwater depth in the PEEP chamber.
-
cuit work together to deliver optimally
rainout.
Pulse Oximetry Monitoring
The Dolphin CPAP incorporates
Masimo SET
®
technology to provide ac-
curate, reliable and robust monitoring of a
patient’s pulse rate and functional oxygen
saturation of arterial hemoglobin (SpO
2
).
system is included to notify staff in the
event that measured vital signs fall out-
side of their target ranges.
Indications for use
The Bubble CPAP Therapy provided by the device is indicated for the respiratory
support of spontaneously breathing neonatal patients with mild to severe idiopathic
respiratory distress syndrome (RDS), mild to severe apnea, atelectasis, hyaline
membrane disease (HMD), meconium aspiration syndrome (MAS), transient
tachypnea of the neonate (TTN) or lung edema. The device is indicated for use in a
hospital setting. The device is not indicated for use with patients whose upper airways
have been bypassed.
The Pulse Oximetry Monitoring provided by the device is indicated for the
continuous, non-invasive monitoring of functional oxygen saturation of arterial
hemoglobin (SpO
2
). The device and its accessories are indicated for use with neonatal
patients during both motion and no motion conditions, who are well or poorly
perfused patients in a hospital setting.